| 1551 |
TREVIA TABLETS 100 MG |
SITAGLIPTIN PHOSPHATE MONOHYDRATE EQ.TO SITAGLIPTIN 100 MG |
FILM-COATED TABLETS |
ALU-ALU |
TREVIA ( SITAGLITIN) IS INDICATED IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AS AN ADJUNCT KTO DIET AND EXERCISE TO IMPROVE GLYCEMIC CONTROL. |
NULL |
LAO INTER PHARMA CO.,LTD |
GETZ PHARMA (PRIVATE) LIMITED |
PAKISTAN |
CERTIFICATE RELEASED |
11 I 4110/15 |
19-Apr-2023 |
18-Apr-2026 |
View |
| 1552 |
TREVIA TABLETS 50 MG |
SITAGLIPTIN PHOSPHATE MONOHYDRATE EQ.TO SITAGLIPTIN 50 MG |
FILM-COATED TABLETS |
ALU-ALU |
TREVIA ( SITAGLIPTIN) IS INDICATED IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AS AN ADJUNCT TO DIET AND EXERCISE TO IMPROVE GLYCEMIC CONTROL. |
NULL |
LAO INTER PHARMA CO.,LTD |
GETZ PHARMA (PRIVATE) LIMITED |
PAKISTAN |
CERTIFICATE RELEASED |
11 I 4113/15 |
10-Feb-2023 |
09-Feb-2026 |
View |
| 1553 |
TREVIAMET TABLETS 50 MG+1000 MG |
METFORMIN HCL 1000 MG, SITAGLIPTIN PHOSPHATE 61.520 MG EQ.TO SITAGLIPTIN 50 MG
|
FILM-COATED TABLETS |
BLISTERPACK |
TREVIAMET IS INDICATED : INITIAL THERAPY IN PATIENTS WITH TYPE 2 DIABETES MELLITUS TO IMPROVE GLYCEMIC CONTROL WHEN DIET AND EXCERCISE DO NOT PROVIDE ADEQUATE GLYCEMIC CONTROL |
NULL |
LAO INTER PHARMA CO.,LTD |
GETZ PHARMA (PRIVATE) LIMITED |
PAKISTAN |
CERTIFICATE RELEASED |
11 I 4117/15 |
10-Feb-2023 |
09-Feb-2026 |
View |
| 1554 |
TREVIAMET TABLETS 50 MG+500 MG |
SITAGLIPTIN PHOSPHATE MONOHYDRATE EQ.TO SITAGLIPTIN 50 MG. METFORMIN HCL USP 500 MG |
FILM-COATED TABLETS |
BLISTERPACK |
TREVIAMET IS INDICATED : INITIAL THERAPY IN PATIENTS WITH TYPE 2 DIABETES MELLITUS TO IMPROVE GLYCEMIC CONTROL WHEN DIET AND EXCERCISE DO NOT PROVIDE ADEQUATE GLYCEMIC CONTROL |
NULL |
LAO INTER PHARMA CO.,LTD |
GETZ PHARMA (PRIVATE) LIMITED |
PAKISTAN |
CERTIFICATE RELEASED |
11 I 4118/15 |
10-Feb-2023 |
09-Feb-2026 |
View |
| 1555 |
VERBITAL |
PHENOBARBITAL SODIUM BP 200 MG/2ML |
SOLUTION FOR INJECTION |
AMPOULES |
FOR THE TREATMENT ALL FORMS OF EPILEPSY EXCEPT ABSENCE SEIZURES |
NULL |
LAO INTER PHARMA CO.,LTD |
VERVE HUMAN CARE LABOLATORIES |
INDIA |
CERTIFICATE RELEASED |
06 I 4745/19 |
26-AUG-2024 |
25-AUG-2027 |
View |
| 1556 |
VERBITAL -100 |
PHENOBARBITAL SODIUM BP 100 MG |
TABLET |
BLISTERPACK |
TREATING AND PREVENTING SEIZURES, AND TREATING SLEEP DISORDERS. IT MAY ALSO BE USED FOR THE OTHER CONDITIONS AS DETERMINED BY YOUR DOCTOR |
NULL |
LAO INTER PHARMA CO.,LTD |
VERVE HUMAN CARE LABOLATORIES |
INDIA |
CERTIFICATE RELEASED |
06 I 4746/19 |
26-AUG-2024 |
25-AUG-2027 |
View |
| 1557 |
VERDOL |
TRAMADOL HYDROCHLORIDE BP 100 MG/2ML |
SOLUTION FOR INJECTION |
AMPOULES |
FOR THE MANAGEMENT OF MODERATE TO MODERATELY SEVERE PAIN |
NULL |
LAO INTER PHARMA CO.,LTD |
VERVE HUMAN CARE LABOLATORIES |
INDIA |
CERTIFICATE RELEASED |
12 I 4863/19 |
26-AUG-2024 |
25-AUG-2027 |
View |
| 1558 |
VERFEN |
FENTANYL CITRATE USP EQ.TO FENTANYL 100 MCG/2ML |
SOLUTION FOR INJECTION |
AMPOULES |
FOR ANALGESIC ACTION OF SHORT DURATION DURING THE ANESTHETIC PEROIDS, PREMEDICATION, INDUCTION AND MAINTENANCE, AND IN THE IMMEDIATE POSTOPERATIVE PEROID AS THE NEDD ARISES; FOR USE AS A NARCOTIC ANALGESIC SUPPLEMENT IN GENERAL OR REGIONAL ANESTHESIA |
NULL |
LAO INTER PHARMA CO.,LTD |
VERVE HUMAN CARE LABOLATORIES |
INDIA |
CERTIFICATE RELEASED |
12 I 4861/19 |
26-AUG-2024 |
25-AUG-2027 |
View |
| 1559 |
VERMOR-10 |
MORPHINE SULFATE BP 10 MG/ML |
SOLUTION FOR INJECTION |
AMPOULES |
RELIEF OF SEVERE PAIN, IT IS USED PREOPERATIVELY TO SEDATE THE PATIENT AND ALLAY APPREHENSION, FACILITATE ANESTHESIA INDUCTION AND REDUCE ANESTHETIC DOASGE. IT IS LIKEWISE EFFECTIVE IN THE CONTROL OF POSTOPERATIVE PAIN |
NULL |
LAO INTER PHARMA CO.,LTD |
VERVE HUMAN CARE LABOLATORIES |
INDIA |
CERTIFICATE RELEASED |
06 I 4747/19 |
26-AUG-2024 |
25-AUG-2027 |
View |
| 1560 |
VERMOR-30 |
MORPHINE SULFATE BP 30 MG |
TABLET |
ALUMINIUM FOIL |
FOR THE PROLONGED RELIEF OF SEVERE AND INTRACTABLE PAIN AND FOR THE RELIEF OF POST-OPERATIVE PAIN |
NULL |
LAO INTER PHARMA CO.,LTD |
VERVE HUMAN CARE LABOLATORIES |
INDIA |
CERTIFICATE RELEASED |
06 I 4748/19 |
26-AUG-2024 |
25-AUG-2027 |
View |
